The triterpenoid quinonemethide pristimerin inhibits induction of inducible nitric oxide synthase in murine macrophages

European Journal of Pharmacology

Volumn 336, Issue 2-3, 1997, Pages 211-217

  Dirsch, Verena M ^a   Kiemer, Alexandra K ^a   Wagner, Hildebert ^b   Vollmar, Angelika M ^a  

^a Toxicol Pharm Ludwig M   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Inducible; Inflammation; NO synthase; Pristimerin; RAW 264.7 macrophages; Triterpene

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE SYNTHASE; NITRITE; PRISTIMERIN; TRITERPENOID;

ARTICLE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MACROPHAGE; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

CELL LINE; CYCLOOXYGENASE 2; ENZYME INDUCTION; ISOENZYMES; LIPOPOLYSACCHARIDES; MACROPHAGES; NF-KAPPA B; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRROLIDINES; THIOCARBAMATES; TRITERPENES;

EID: 0030668219     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01245-4     Document Type: Article

References (24)

1. Appleton, I., Tomlinson, A., Willoughby, D.A., 1996. Induction of cyclooxygenase and nitric oxide synthase in inflammation. In: August, J.T., Anders, M.W., Murad, F., Coyle, J.T. (Eds.), Advances in Pharmacology, vol. 35. Academic Press, San Diego, CA, pp. 27-78.
2. Boese M., Busse R., Mülsch A., Schini-Kerth V. Effect of cyclic GMP-dependent vasodilators on the expression of inducible nitric oxide synthase in vascular smooth muscle cells: Role of cyclic AMP. Br. J. Pharmacol. 119:1996;707-715.
3. Clancy R.M., Abramson S.B. Nitric oxide: A novel mediator of inflammation. Proc. Soc. Exp. Biol. Med. 210:1995;93-101.
4. Cochran F.R., Selph J., Sherman P. Insights into the role of nitric oxide in inflammatory arthritis. Med. Res. Rev. 16:1996;547-563.
5. Dirsch V., Wiemann W., Wagner H. Antiinflammatory activity of triterpene quinone-methides and proanthocyanidines from the stem bark of Heisteria pallida. Engl. Pharm. Pharmacol. Lett. 2:1992;184-186.
6. Förstermann U., Kleinert H. Nitric oxide synthase: Expression and expressional control of the three isoforms. Naunyn-Schmiedebergs Arch. Pharmacol. 352:1995;351-364.
7. 15N ]nitrate in biological fluids Anal. Biochem. 126:1982;131-138.
8. Gunatilaka, A.A.L., 1996. Triterpenoid quinonemethides and related compounds (celastroloids). In: Herz, W., Kirby, G.W., Moore, R.E., Steglich, W., Tamm, Ch. (Eds.), Progress in the Chemistry of Organic Natural Products, vol. 67. Springer, Vienna/New York, pp. 1-176.
9. Kleinert H., Euchenhofer C., Ihrig-Biedert I., Förstermann U. Glucocorticoids inhibit the induction of nitric oxide synthase II by down- regulating cytokine-induced activity of transcription factor nuclear factor-kappa B. Mol. Pharmacol. 49:1996;15-21.
10. Martin E., Nathan C., Xie Q.-W. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180:1994;977-984.
11. Miller M.J.S., Grisham M.B. Nitric oxide as a mediator of inflammation? You had better believe it. Mediators Inflammation. 4:1995;387-396.
12. Monks A., Scudiero D., Skehan P., Shoemaker R., Paull K., Vistica D.T., Hose C., Langley J., Cronise P., Vaigro-Wolff A., Gray-Goodrich M., Campell H., Mayo J., Boyd M.R. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl. Cancer Inst. 83:1991;757-766.
13. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
14. Nathan C., Xie Q.-W. Nitric oxide synthases: Roles, tolls, and controls. Cell. 78:1994;915-918.
15. Rothe H., Bosse G., Fischer H.G., Kolb H. Generation and characterization of inducible nitric oxide synthase deficient macrophage cell lines. Biol. Chem. Hoppe Seyler. 377:1996;227-231.
16. Schreiber E., Matthias P., Müller M.M., Schaffner W. Rapid detection of octamer binding proteins with 'mini extracts', prepared from a small number of cells. Nucleic Acids Res. 17:1989;6419.
17. Schulze-Osthoff K., Los M., Baeuerle P.A. Redox signalling by transcription factors NFκB and AP-1 in lymphocytes. Biochem. Pharmacol. 50:1995;735-741.
18. Stuehr D.J., Cho H.J., Kwon N.S., Weise M.F., Nathan C.F. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: An FAD- and FMN-containing flavoprotein. Proc. Natl. Acad. Sci. USA. 88:1991;7773-7777.
19. Thiemermann C., Wu C.C., Szabo C., Perretti M., Vane J.R. Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock. Br. J. Pharmacol. 110:1993;177-182.
20. Togashi H., Sasaki M., Frohman E., Taira E., Ratan R.R., Dawson T.M., Dawson V.L. Neuronal (type I) nitric oxide synthase regulates nuclear faktorκB activity and immunologic (type II) nitric oxide synthase expression. Proc. Natl. Acad. Sci. USA. 94:1997;2676-2680.
21. Tsujino M., Hirata Y., Imai T., Kanno K., Eguchi S., Ito H., Marumo F. Induction of nitric oxide synthase gene by interleukin-1 beta in cultured rat cardiocytes. Circulation. 90:1994;375-383.
22. Vollmar A.M., Schulz R. Gene expression and secretion of atrial natriuretic peptide by murine macrophages. J. Clin. Invest. 94:1994;539-545.
23. Xie Q.-W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:1994;4705-4708.
24. Yamamoto K., Arakawa T., Ueda N., Yamamoto S. Transcriptional roles of nuclear factor κB and nuclear factor-interleukin-6 in the tumor necrosis factor α- dependent induction of cyclooxygenase 2 in MC3T3-E1 cells. J. Biol. Chem. 270:1995;31315-31320.